EZH2 and cancer: There was significant overlap; 8/14 genes involved in OGID were somatically mutated in a diverse range of cancers (NSD1, EZH2, DNMT3A, PTEN, CHD8, HIST1H1E, MTOR, PIK3CA; p = 1.7 × 10−14).